Home » Erik Schneider

Erik Schneider

Senior Manager

Erik Schneider was a Senior Manager at CBPartners.

Connect with Erik Schneider



Published Articles

Deal With It: FTC Regulation of Innovative Biopharmaceuticals Escalates During Record-Breaking M&A Streak

Amid a streak of health care merger and acquisition (M&A) activity in 2018 and 2019, the Federal Trade Commission (FTC) is taking an aggressive stance in its review of biopharmaceutical deals. CBPartners analyses what this means for pharmaceutical M&A.